Kailera Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell KLRA and other ETFs, options, and stocks.About KLRA
Kailera Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the development of a broad, advanced, and differentiated portfolio of clinical-stage injectable and oral therapies for the treatment of obesity. Its product candidate includes Ribupatide.
KLRA Key Statistics
Stock Snapshot
Kailera Therapeutics(KLRA) stock is priced at $23.30, giving the company a market capitalization of 3.11B.
On 2026-05-06, Kailera Therapeutics(KLRA) stock moved within a range of $23.30 to $25.50. With shares now at $23.30, the stock is trading 0.0% above its intraday low and -8.6% below the session's peak.
Trading volume for Kailera Therapeutics(KLRA) stock has reached 425.2K, versus its average volume of 1.05M.
Over the past 52 weeks, Kailera Therapeutics(KLRA) stock has traded between a high of $28.23 and a low of $16.00.
Over the past 52 weeks, Kailera Therapeutics(KLRA) stock has traded between a high of $28.23 and a low of $16.00.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.